Ignite Creation Date:
2024-05-05 @ 11:08 AM
Last Modification Date:
2024-10-26 @ 9:01 AM
Study NCT ID:
NCT00000273
Status:
COMPLETED
Last Update Posted:
2017-07-05
First Post:
1999-09-20
Brief Title:
A Laboratory Model for Heroin Abuse Medications - 8
Sponsor:
New York State Psychiatric Institute
Organization:
New York State Psychiatric Institute
Study Overview
Official Title:
A Laboratory Model for Heroin Abuse Medications
Status:
COMPLETED
Status Verified Date:
2017-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the effects of treatment medications methadone buprenorphine LAAM naltrexone naltrexone microcapsules and methoclocinnamox on IV and smoked heroin self-administration
Detailed Description:
Abuse of prescription opioid medications has increased dramatically in the US during the past decade as indicated by a variety of epidemiological sources However few studies have systematically examined the relative reinforcing effects of commonly abused opioid medications The current inpatient study was designed to compare the effects of intravenously delivered fentanyl oxycodone morphine buprenorphine and heroin in morphine-maintained heroin abusers All of the participants received all of the drugs tested drugs and doses were administered in non-systematic order
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 5P50DA009236-18 | NIH | None | httpsreporternihgovquickSearch5P50DA009236-18 |